Rogers Corporation — Q2 2023 Form 10-Q Summary
Business Context and Reporting Period
Rogers Corporation designs and manufactures engineered materials and components serving advanced electronics, electric and hybrid vehicles, automotive, aerospace and defense, renewable energy, communications, industrial and other markets. Its principal operating segments are Advanced Electronics Solutions (AES) and Elastomeric Material Solutions (EMS), with remaining businesses reported as Other. The unaudited interim filing covers the three and six months ended June 30, 2023, compared with the corresponding 2022 periods.
Financial Performance and Position
| Metric | Q2 2023 | Q2 2022 | H1 2023 | H1 2022 |
|---|---|---|---|---|
| Net sales | $230.8 million | $252.0 million | $474.7 million | $500.2 million |
| Gross margin | $79.6 million; 34.5% | $86.5 million; 34.3% | $159.3 million; 33.6% | $171.9 million; 34.4% |
| Operating income | $27.9 million; 12.1% | $23.4 million; 9.3% | $27.6 million; 5.8% | $43.3 million; 8.7% |
| Net income | $17.9 million | $17.9 million | $14.4 million | $34.5 million |
| Diluted EPS | $0.96 | $0.94 | $0.77 | $1.82 |
| Operating cash flow | Six-month measure: $17.5 million | 2022 six-month measure: $(11.7) million |
- Q2 sales declined 8.4%; AES sales declined 7.8% and EMS sales declined 9.3%. Sales were pressured by weaker wireless infrastructure, aerospace and defense, portable electronics, general industrial, automotive and certain EV/HEV demand.
- Q2 gross margin improved 20 basis points year over year due primarily to lower freight, duties and tariffs and favorable EMS factory utilization, partly offset by lower volume, unfavorable mix, yield issues and higher inventory reserves.
- Q2 operating income increased despite lower sales, supported by lower SG&A and $6.2 million of UTIS fire insurance recoveries recorded in other operating income. Six-month operating income declined substantially because of restructuring charges, lower volume and mix, and non-routine shareholder advisory costs.
- As of June 30, 2023, cash and equivalents were $141.5 million versus $235.9 million at December 31, 2022. Accounts receivable were $186.7 million and inventories were $169.7 million.
- Six-month investing cash use was $24.6 million, including $27.9 million of capital expenditures. Financing cash use was $89.5 million, primarily reflecting $85.0 million of discretionary revolving-credit repayments.
- Borrowings under the revolving credit facility were $130.0 million, down from $215.0 million at year-end. The amended facility provides $450.0 million of revolving capacity plus a $225.0 million expansion feature and matures March 24, 2028. The June 30 leverage and interest-coverage covenants were satisfied.
Material Changes Versus the Prior Comparable Period
- Q2 revenue decreased $21.1 million, while net income was essentially unchanged because lower SG&A, restructuring-related effects and insurance recoveries offset lower sales and higher interest expense.
- Q2 SG&A fell 17.8% to $46.1 million, primarily from lower professional services, compensation and benefits, amortization and depreciation.
- Q2 interest expense increased to $2.8 million from $1.5 million, primarily due to higher average interest rates.
- Six-month effective tax rate increased to 33.2% from 22.2%, primarily because of increased valuation allowances in loss jurisdictions and lower excess tax benefits from stock compensation.
- Restructuring charges increased to $3.9 million in Q2 and $14.4 million for the first half, versus $0.7 million and $0.7 million, respectively, in the prior-year periods. The charges related to workforce reductions and facility consolidations.
- AES Q2 operating income declined to $5.8 million from $8.8 million; EMS operating income increased to $20.2 million from $12.6 million. Six-month AES operating income was only $0.3 million versus $10.1 million, while EMS operating income was $23.4 million versus $29.6 million.
Outlook, Commentary, Risks and Unusual Items
- Management expects 2023 capital spending of approximately $65 million to $75 million and believes cash on hand, operating cash flow and available borrowing capacity will fund operations, planned capital expenditures, R&D and debt service for at least the next 12 months.
- Management is pursuing manufacturing-footprint optimization, facility consolidations, workforce reductions, divestitures and operational improvements, with the objective of reducing costs and returning to historical profitability levels over the next several years.
- Management highlights EV/HEV, ADAS, aerospace and defense, portable electronics and renewable energy as important growth markets. The filing does not provide formal quarterly or full-year revenue or earnings guidance.
- The company recognized $6.7 million of UTIS fire insurance recoveries in the first half, including $6.2 million in Q2. These recoveries materially benefited reported operating results and may not recur at the same level.
- Rogers expects to complete the sale of its high-performance engineered cellular elastomer business and related land and building transaction in the third quarter. It also agreed in July 2023 to sell its Price Road facility for $18.8 million, expected to close late in Q3.
- The terminated DuPont merger generated a $162.5 million pre-tax regulatory termination fee in 2022 but also created transaction-related costs. The filing identifies ongoing risks from the terminated merger, including possible litigation and additional costs.
- Material risks include cyclical and end-market demand, China and other international operations, tariffs and trade restrictions, foreign exchange, supply-chain and commodity risks, technology and competitive pressures, restructuring execution, covenant compliance, tax matters, cybersecurity, environmental matters and asbestos litigation.
- Asbestos-related liabilities were $64.9 million and related insurance receivables were $59.8 million at June 30, 2023. There were 557 outstanding claims, and management cautions that future claims, insurance coverage and insurer solvency could cause actual costs and recoveries to differ from estimates.
Important Facts for Investors to Verify
- Whether sales weakness in wireless infrastructure, portable electronics, industrial and automotive markets stabilizes and whether EV/HEV and renewable-energy growth offsets declines elsewhere.
- Whether restructuring and footprint actions deliver the expected cost savings after the stated $14.4 million of first-half charges and remaining estimated facility-consolidation costs.
- The sustainability and timing of UTIS insurance recoveries and the effect of their eventual reduction on operating income and cash flow.
- Progress toward the $65 million–$75 million 2023 capital-spending plan, cash generation and further discretionary debt repayment.
- Compliance with the amended credit agreement, including the 3.25-to-1.00 total net leverage limit, 3.00-to-1.00 minimum interest-coverage ratio and dividend restrictions.
- Completion and proceeds of the announced business and facility sales, including the expected third-quarter closings.
- Trends in asbestos claims, insurance coverage and potential uninsured litigation costs, as well as changes in the $9.0 million of unrecognized tax benefits.